• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋天然化合物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的有效抑制剂——一项分子动力学研究

Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.

作者信息

Khan Muhammad Tahir, Ali Arif, Wang Qiankun, Irfan Muhammad, Khan Abbas, Zeb Muhammad Tariq, Zhang Yu-Juan, Chinnasamy Sathishkumar, Wei Dong-Qing

机构信息

Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Pakistan.

State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, China Shanghai.

出版信息

J Biomol Struct Dyn. 2021 Jul;39(10):3627-3637. doi: 10.1080/07391102.2020.1769733. Epub 2020 Jun 1.

DOI:10.1080/07391102.2020.1769733
PMID:32410504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7284144/
Abstract

Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA) virus, responsible for severe acute respiratory disease (COVID-19). A large number of natural compounds are under trial for screening compounds, possessing potential inhibitory effect against the viral infection. Keeping in view the importance of marine compounds in antiviral activity, we investigated the potency of some marine natural products to target SARS-CoV-2 main protease (M) (PDB ID 6MO3). The crystallographic structure of M in an apo form was retrieved from Protein Data Bank and marine compounds from PubChem. These structures were prepared for docking and the complex with good docking score was subjected to molecular dynamic (MD) simulations for a period of 100 ns. To measure the stability, flexibility, and average distance between the target and compounds, root mean square deviations (RMSD), root mean square fluctuation (RMSF), and the distance matrix were calculated. Among five marine compounds, C-1 (PubChem CID 11170714) exhibited good activity, interacting with the active site and surrounding residues, forming many hydrogen and hydrophobic interactions. The C-1 also attained a stable dynamic behavior, and the average distance between compound and target remains constant. In conclusion, marine natural compounds may be used as a potential inhibitor against SARS-CoV-2 for better management of COVID-19.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种单链RNA(ssRNA)病毒,可导致严重急性呼吸疾病(COVID-19)。大量天然化合物正在进行筛选,以寻找对病毒感染具有潜在抑制作用的化合物。鉴于海洋化合物在抗病毒活性方面的重要性,我们研究了一些海洋天然产物针对SARS-CoV-2主要蛋白酶(M)(PDB ID 6MO3)的效力。从蛋白质数据库中检索了无配体形式的M的晶体结构,并从PubChem中获取了海洋化合物。对这些结构进行对接准备,对接分数良好的复合物进行了100纳秒的分子动力学(MD)模拟。为了测量目标与化合物之间的稳定性、灵活性和平均距离,计算了均方根偏差(RMSD)、均方根波动(RMSF)和距离矩阵。在五种海洋化合物中,C-1(PubChem CID 11170714)表现出良好的活性,与活性位点和周围残基相互作用,形成了许多氢键和疏水相互作用。C-1还表现出稳定的动力学行为,化合物与目标之间的平均距离保持恒定。总之,海洋天然化合物可作为SARS-CoV-2的潜在抑制剂,用于更好地管理COVID-19。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82d/7284144/038dea8e2698/TBSD_A_1769733_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82d/7284144/038dea8e2698/TBSD_A_1769733_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82d/7284144/038dea8e2698/TBSD_A_1769733_UF0001_C.jpg

相似文献

1
Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.海洋天然化合物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的有效抑制剂——一项分子动力学研究
J Biomol Struct Dyn. 2021 Jul;39(10):3627-3637. doi: 10.1080/07391102.2020.1769733. Epub 2020 Jun 1.
2
Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape.解析海洋药物作为 SARS-CoV-2 抑制剂的治疗潜力:从本征动力学和自由能景观角度的深入了解。
Comput Biol Med. 2021 Aug;135:104525. doi: 10.1016/j.compbiomed.2021.104525. Epub 2021 May 29.
3
A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition.一种用于预测 SARS-CoV-2 主蛋白酶抑制的计算机辅助药物设计方法:海洋类药物先导物。
Mar Drugs. 2020 Dec 10;18(12):633. doi: 10.3390/md18120633.
4
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
5
Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study.黑种草中提取的百里醌对 SARS-CoV-2 主蛋白酶的抑制作用。一项计算机模拟研究。
Braz J Biol. 2022 Apr 15;84:e250667. doi: 10.1590/1519-6984.25066. eCollection 2022.
6
Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach.基于结构的抗 SARS-CoV-2 主蛋白酶抑制剂的抗病毒专用化学文库筛选:一种详尽的计算筛选方法。
Mol Divers. 2021 Aug;25(3):1979-1997. doi: 10.1007/s11030-021-10214-6. Epub 2021 Apr 12.
7
Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies.基于结构的药效团模型构建、分子对接和分子动力学模拟研究 SARS-CoV-2 主要蛋白酶的天然抑制剂。
J Mol Model. 2022 Aug 29;28(9):279. doi: 10.1007/s00894-022-05286-6.
8
Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus : An In Silico Study for Drug Development.从属中鉴定潜在的 SARS-CoV-2 主要蛋白酶和刺突蛋白抑制剂:药物开发的计算研究。
Molecules. 2021 Mar 21;26(6):1767. doi: 10.3390/molecules26061767.
9
Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.计算引导鉴定柑橘类黄酮作为 SARS-CoV-2 主蛋白酶潜在抑制剂
Mol Divers. 2021 Aug;25(3):1745-1759. doi: 10.1007/s11030-020-10150-x. Epub 2020 Nov 25.
10
Computational screening for potential drug candidates against the SARS-CoV-2 main protease.针对 SARS-CoV-2 主蛋白酶的潜在药物候选物的计算筛选。
F1000Res. 2020 Jun 4;9. doi: 10.12688/f1000research.23829.2. eCollection 2020.

引用本文的文献

1
Molecular docking, pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and spike protein.针对新型冠状病毒2型主要蛋白酶和刺突蛋白的糖酵解抑制剂的分子对接、药理学分析及分子动力学模拟
In Silico Pharmacol. 2025 Mar 14;13(1):44. doi: 10.1007/s40203-025-00336-2. eCollection 2025.
2
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M.严重急性呼吸综合征冠状病毒2 M蛋白的结构与功能、免疫逃逸机制、抗病毒药物研发方法及临床应用研究进展
Molecules. 2025 Jan 16;30(2):351. doi: 10.3390/molecules30020351.
3

本文引用的文献

1
Four ways researchers are responding to the COVID-19 outbreak.研究人员应对新冠疫情的四种方式。
Nat Med. 2020 Feb 19. doi: 10.1038/d41591-020-00002-4.
2
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.利用分子对接研究鉴定 SARS-CoV-2 主蛋白酶潜在抑制剂的研究。
J Biomol Struct Dyn. 2021 Jun;39(9):3347-3357. doi: 10.1080/07391102.2020.1763201. Epub 2020 May 13.
3
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.
2019-2021 年海洋药理学:具有抗菌、抗糖尿病、抗真菌、抗炎、抗原生动物、抗结核和抗病毒活性的海洋化合物;影响免疫系统和神经系统以及其他各种作用机制。
Mar Drugs. 2024 Jun 30;22(7):309. doi: 10.3390/md22070309.
4
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects.海洋天然产物在抗SARS-CoV-2抗病毒药物研发中的作用:潜力与前景
Mar Life Sci Technol. 2024 Feb 21;6(2):280-297. doi: 10.1007/s42995-023-00215-9. eCollection 2024 May.
5
Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.海洋来源的生物活性代谢产物作为治疗病毒性疾病的潜在干预措施:来自SARS-CoV-2计算机模拟和临床前研究的见解
Pharmaceuticals (Basel). 2024 Mar 1;17(3):328. doi: 10.3390/ph17030328.
6
Pharmacophore study, molecular docking and molecular dynamic simulation of virgin coconut oil derivatives as anti-inflammatory agent against COX-2.初榨椰子油衍生物作为抗COX-2炎症剂的药效团研究、分子对接和分子动力学模拟
Chem Biol Technol Agric. 2022;9(1):73. doi: 10.1186/s40538-022-00340-0. Epub 2022 Oct 18.
7
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.通过天然产物对抗 COVID-19:药物化学家的各种尝试的全面更新。
Molecules. 2023 Jun 20;28(12):4860. doi: 10.3390/molecules28124860.
8
An overview on medicinal plants used for combating coronavirus: Current potentials and challenges.用于对抗冠状病毒的药用植物综述:当前的潜力与挑战
J Agric Food Res. 2023 Sep;13:100632. doi: 10.1016/j.jafr.2023.100632. Epub 2023 May 20.
9
Advanced Methods for Natural Products Discovery: Bioactivity Screening, Dereplication, Metabolomics Profiling, Genomic Sequencing, Databases and Informatic Tools, and Structure Elucidation.天然产物发现的先进方法:生物活性筛选、去重复、代谢组学分析、基因组测序、数据库和信息工具以及结构解析。
Mar Drugs. 2023 May 19;21(5):308. doi: 10.3390/md21050308.
10
Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function.预测罕见基因变异对致癌信号通路的影响:HRAS蛋白功能的计算分析
Front Chem. 2023 Apr 21;11:1173624. doi: 10.3389/fchem.2023.1173624. eCollection 2023.
从印度香料中鉴定新型抗 nCoV 药物化合物,利用 SARS-CoV-2 主要蛋白酶作为靶点。
J Biomol Struct Dyn. 2021 Jun;39(9):3428-3434. doi: 10.1080/07391102.2020.1763202. Epub 2020 May 13.
4
Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures.使用不同温度下的 MD 模拟研究荷叶碱与 SARS-CoV-2 蛋白酶对 COVID-19 的结合亲和力。
J Biomol Struct Dyn. 2021 Apr;39(7):2659-2672. doi: 10.1080/07391102.2020.1752310. Epub 2020 May 4.
5
study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by components harvested from Western Algeria.研究从阿尔及利亚西部采集的成分对 COVID-19 血管紧张素转化酶 2 受体的抑制作用。
J Biomol Struct Dyn. 2021 Jun;39(9):3263-3276. doi: 10.1080/07391102.2020.1763199. Epub 2020 May 14.
6
Stilbene-based natural compounds as promising drug candidates against COVID-19.基于芪类的天然化合物有望成为抗击 COVID-19 的药物候选物。
J Biomol Struct Dyn. 2021 Jun;39(9):3225-3234. doi: 10.1080/07391102.2020.1762743. Epub 2020 May 12.
7
An evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets.评价不同柴胡皂苷对 SARS-CoV-2 的效力,以 NSP15 和融合刺突糖蛋白作为靶点。
J Biomol Struct Dyn. 2021 Jun;39(9):3244-3255. doi: 10.1080/07391102.2020.1762741. Epub 2020 May 13.
8
A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2.采用分子建模方法鉴定抗 SARS-CoV-2 主蛋白酶的有效抗病毒植物化学物质。
J Biomol Struct Dyn. 2021 Jun;39(9):3213-3224. doi: 10.1080/07391102.2020.1761883. Epub 2020 May 12.
9
Natural products may interfere with SARS-CoV-2 attachment to the host cell.天然产物可能会干扰 SARS-CoV-2 与宿主细胞的附着。
J Biomol Struct Dyn. 2021 Jun;39(9):3194-3203. doi: 10.1080/07391102.2020.1761881. Epub 2020 May 5.
10
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an perspective.靶向 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp):一个研究视角。
J Biomol Struct Dyn. 2021 Jun;39(9):3204-3212. doi: 10.1080/07391102.2020.1761882. Epub 2020 May 6.